018290

VT is a South Korean conglomerate operating in four main business segments: cosmetics, laminating, housing construction, and biotechnology. The cosmetics division, which generates the majority of revenue, develops and sells skincare and personal care products under the VT Cosmetics brand, utilizing OEM and ODM production methods with partners such as Cosmax Korea and its subsidiary ENC. Key products include the Cica Daily Soothing Mask and the Redshot line, distributed through major retail chains like Olive Young and Daiso in Korea, drugstores in Japan, and online and offline channels in North America. The laminating segment manufactures high-value laminating machines and films, including the Thermalami System and various film products like Polynex and Nylonex, serving the digital printing, packaging, and industrial sectors globally. The company also designs and manufactures induction heating rollers for advanced manufacturing applications, including secondary battery and flexible copper clad laminate production. In the biotechnology sector, the subsidiary VT Bio focuses on developing cell-based therapies for neurodegenerative diseases, specifically a regulatory T-cell therapy for Alzheimer's disease, and natural product drugs, while also marketing health functional foods such as Finitol Polyver and Librain. The housing segment engages in residential construction and infrastructure development projects.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Conglomerates Homepage vtgmpcorp.co.kr
Sector Industrials IR page —
Tags
cosmetics, laminating machines, laminating films, induction heating rollers, cell therapy, neurodegenerative diseases, health functional foods, residential construction, oem/odm, digital printing, VT Cosmetics, Cica Daily Soothing Mask, Redshot, ENC, Thermalami System, Polynex, Nylonex, Perfect, Photonex, Light Protect, SuperTouch, Pronex, Crystalex, Micronex, Silkfeel Film, Sleeking Film, Tigerbond, ExcelBond, Securegram, Lamigra, Challenger, Pioneer, Eurolam, PODMaster, Protopic 540, QTopic-380, PODTopic-RZ, LAMIMASTER IDH-54 PAIR DUPLEX HS 150, VT Bio, VT301, VT012, VT014, Bronpass, Finitol Polyver, Librain, Dr.VT, Goodmedy
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 25.7%
ROI 25.1%
ROIC 27.2%
Profit margin 13.9%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 76.1%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score 46.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 437.184B 431.697B 295.501B 240.241B 226.77B 107.395B 112.757B 109.47B 69.86B 41.141B 47.027B 53.825B 52.606B
Net profit 60.933B 98.044B 27.268B 11.149B 14.914B 1.105B 2.834B 6.973B -14.452B -14.565B -24.041B -3.628B 1.177B
Free cash flow 46.186B 83.546B 24.509B 52.055B 46.772B -5.233B -8.084B -12.26B -7.508B -347.375M 2.422B 106.346M 676.712M

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 5.24B 9.96B 26.4B 33.3B 22.3B 33.8B 36.9B 56.7B 54.1B 46.9B
↳ YoY growth -30.8% +89.9% +165.1% +26.2% -33.2% +51.7% +9.4% +53.4% -4.5% -13.3%
↳ 5y CAGR +17.6% +23.8% +24.1% +45.1% +30.0% +16.5% +10.2% +16.1%
Borrowings, current (KRW) 7.44B 18.9B 12.4B 40.8B 58B 42.1B 26.5B 24.6B 47.7B 36.4B
Borrowings, non-current (KRW) 5.13B 4.25B 10.9B 13.3B 3.45B — — 0.00 8.24B 0.00
Bonds payable (KRW) 5.13B 21.6B 6.63B 14.9B 13.6B 22.4B 6.3B — — —
Cash and deposits (KRW) 1.53B 10.8B 17.5B 17.7B 11.1B 33.6B 32.8B 49.8B 41.3B 84.2B
Intangible assets (KRW) 3.48B 293M 359M 756M 664M 9.42B 7.16B 5.19B 10.6B 10.1B
Right-of-use assets (KRW) — — — 1.4B — 6.17B 5.37B 7.57B 1.55B 1.81B
Net debt (borrowings + leases - cash) (KRW) 5.91B 12.4B 5.88B 36.4B 50.4B 8.44B -6.32B -25.2B 14.6B -47.8B
Cash flow detail
Operating cash flow (KRW) 170M -5.54B -11B -3.5B -3.2B 48.8B 54B 31.5B 87.1B 49.7B
Purchases of property, plant and equipment (KRW) -517M -1.96B -1.26B -4.59B -2.03B -2.01B -1.96B -7.02B -3.59B -3.54B
Purchases of intangible assets (KRW) -963M -656M -139M -472M -86.9M -1.1B -1.61B -2.45B -858M -1.24B
Change in receivables (cash effect) (KRW) 2.64B -3.13B — — — — — — — —
Change in inventories (cash effect) (KRW) 4.62B 6.49B — — — — — — — —
Change in payables (cash effect) (KRW) -622M -461M — — — — — — — —
Share buybacks (cash effect) (KRW) -18.3M — -2.25B -14.4B -764,940 -9.1B -5.2B -8.41B -4.76B -30.1B
Interest paid (cash effect) (KRW) -737M -480M -229M -48.5M -1.45B -1.43B -1.39B -822M -1.92B -1.76B
Income taxes paid (cash effect) (KRW) -34M -2.07B -831M -2.93B -52.8M -927M -3.83B -1.15B -9.35B -36.6B
Share-based compensation (KRW) 32.2M -32.2M — — — — — — — —
Operating cash flow before change in receivables (KRW) -2.47B -2.41B — — — — — — — —
Free cash flow (OCF - PPE - intangibles) (KRW) -1.31B -8.16B -12.4B -8.56B -5.32B 45.7B 50.4B 22.1B 82.7B 44.9B
Income detail
Total comprehensive income (KRW) -14.6B -13.1B 10.5B 3.23B -1.32B 20.4B 13B 32B 103B 64B
Comprehensive income to owners (KRW) -14.6B -14.5B 6.72B 2.65B 1.09B 17.9B 11.1B 27.7B 97.9B 60.7B
Provision for credit losses (KRW) -304M 911M — — — — — — — —
Credit cost ratio (credit losses / average receivables) (%) 4.7% 12.0% — — — — — — — —
Reported Apr 2, 2018 Apr 2, 2018 Apr 1, 2019 May 15, 2020 Mar 22, 2021 Mar 20, 2024 Mar 20, 2024 Mar 19, 2026 Mar 19, 2025 Mar 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

분기보고서 (2026.09) Bull 0 Bear 0 Routine
주요사항보고서(유형자산양수결정) Bull 3 Bear 0 Product/operations
[기재정정]반기보고서 (2026.06) Bull 0 Bear 0 Routine

Prompts

VT (ticker 018290), listed in South Korea.

ETFs Holding VT

ETF Weight in ETF Shares Market value As of
AVEE 0.01% 1,680 $ 13.142K Nov 16, 2026
DEXC 0.00% 1,649 $ 12.159K Nov 12, 2026
DFEM 0.00% 25,860 $ 190.677K Nov 12, 2026
DFAE 0.00% 19,870 $ 146.51K Nov 12, 2026
DFEV 0.00% 4,442 $ 32.753K Nov 12, 2026
DFAX 0.00% 13,353 $ 98.458K Nov 12, 2026
AVEM 0.00% 48,990 $ 383.241K Nov 16, 2026
AVSE 0.00% 910 $ 7,118.79 Nov 16, 2026
AVXC 0.00% 605 $ 4,732.82 Nov 16, 2026